BeiGene’s Brukinsa Receives Marketing Approval in Brazil
China-based biotech BeiGene Inc. (HKG: 6160, SHA: 688235, NASDAQ: BGNE) has announced that it has...
China-based biotech BeiGene Inc. (HKG: 6160, SHA: 688235, NASDAQ: BGNE) has announced that it has...
China-based Fujian Cosunter Pharmaceutical Co., Ltd (SHE: 300436) has announced the receipt of multiple patents...
China-based Sinocelltech Group Ltd (SHA: 688520) has announced that it has received approval from the...
China-based 3SBio Inc. (HKG: 1530) has announced that its multi-center, randomized, double-blind, placebo-controlled study assessing...
Autoimmune disease drug developer Zenas BioPharma, which is based in the US and China, has...
Sino-US biotech LianBio has announced the first patient dosing in a Phase I clinical study...
Innovex Medical Co., Ltd, a non-vascular interventional surgery solutions provider based in Shanghai, has filed...
The National Medical Products Administration (NMPA) website indicates that linperlisib, a Category 1 anti-tumor drug,...
Suzhou-based Ascentage Pharma (HKG: 6855) has announced that it has received approval from the Center...
The National Health Commission (NHC), National Administration of Traditional Chinese Medicine, and the National Bureau...
Chinese biopharmaceutical firm Zai Lab Ltd (NASDAQ: ZLAB, HKG: 9688) released its Q3 2022 earnings...
The 5th China International Import Expo (CIIE) saw the unveiling of a partnership between GlaxoSmithKline...
China-based 3SBio Inc. (HKG: 1530) has announced that the National Medical Products Administration (NMPA) has...
US-based Boston Scientific Corporation (NYSE: BSX) has announced a partnership with Japan-based Omron Healthcare at...
The 5th China International Import Expo (CIIE) saw the announcement of a partnership between Takeda...
China-based Betta Pharmaceuticals Co., Ltd (SHE: 300558) has announced the summary report of a Phase...
China-based biotech BeiGene Inc. (HKG: 6160, SHA: 688235, NASDAQ: BGNE) released its Q3 2022 earnings...
A strategic partnership between China-based Shandong Xinhua Pharmaceutical Co., Ltd (HKG: 0719) and Bayer Consumer...
US-based Medtronic Inc. (NYSE: MDT) has announced a partnership with Shanghai JiaHui International Hospital, unveiled...
ChainGen Bio, a Shanghai-based developer of X-oligo conjugates (XOCs), has reportedly raised RMB 45 million...